Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2010
Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trialCharles Flexner, Camlin Tierney, Robert Gross, et al.Molecules (Basel, Switzerland)|July 22, 2015
Evaluation of the cytotoxicity of structurally correlated p-menthane derivativesLuciana Nalone Andrade, Tamires Cardoso Lima, Ricardo Guimarães Amaral, et al.Plos One|December 27, 2018
No change in health-related quality of life for at-risk U.S. women and men starting HIV pre-exposure prophylaxis (PrEP): Findings from HPTN 069/ACTG A5305Shashi N Kapadia, Chunyuan Wu, Kenneth H Mayer, et al.The Journal of Infectious Diseases|June 27, 2013
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248Adriana Andrade, Susan L Rosenkranz, Anthony R Cillo, et al.AIDS Research and Human Retroviruses|February 20, 2018
Genetic Variation of the Kinases That Phosphorylate Tenofovir and Emtricitabine in Peripheral Blood Mononuclear CellsDominique B Figueroa, Erin P Madeen, Joseph Tillotson, et al.World Journal of Hepatology|March 31, 2017
Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis CDenise C Paranaguá-Vezozzo, Adriana Andrade, Daniel F C Mazo, et al.Plos One|December 25, 2013
Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabineNicholas T Funderburg, Adriana Andrade, Ellen S Chan, et al.Annals of Internal Medicine|November 24, 2015
HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled TrialKaren T Tashima, Laura M Smeaton, Carl J Fichtenbaum, et al.Plos One|March 31, 2017
Antioxidant, antimicrobial, antiparasitic, and cytotoxic properties of various Brazilian propolis extractsRejane Pina Dantas Silva, Bruna Aparecida Souza Machado, Gabriele de Abreu Barreto, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2013
A pilot study assessing the safety and latency-reversing activity of disulfiram in HIV-1-infected adults on antiretroviral therapyAdam M Spivak, Adriana Andrade, Evelyn Eisele, et al.Pageof 6